SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57,619 | -26.1% | 44,323 | 0.0% | 0.07% | -28.3% |
| Q1 2023 | $78,008 | -43.9% | 44,323 | 0.0% | 0.10% | -46.8% |
| Q4 2022 | $139,174 | -35.9% | 44,323 | 0.0% | 0.19% | -33.8% |
| Q3 2022 | $217,000 | -15.9% | 44,323 | 0.0% | 0.28% | +9.3% |
| Q1 2022 | $258,000 | -22.3% | 44,323 | 0.0% | 0.26% | -18.7% |
| Q4 2021 | $332,000 | -16.8% | 44,323 | 0.0% | 0.32% | -13.7% |
| Q3 2021 | $399,000 | -24.9% | 44,323 | 0.0% | 0.37% | -19.9% |
| Q2 2021 | $531,000 | – | 44,323 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |